HirstA, SloanR. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database of Systematic Reviews, 2001; 4Art. No.: CD003346.10.1002/14651858.CD003346.
2.
SchenckCH, MahowaldMW, SackRL. Assessment and management of insomnia. JAMA, 2003; 289:2475–2479.
3.
CohrsS. Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs, 2008; 22,11:939–962.
4.
WineJN, SandaC, CaballeroJ. Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions. Ann Pharmacother, 2009; 43,4:707–713.
5.
BuscemiN, VandermeerB, HootonNet al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ, 2006; 332,7538:385–393.
6.
RothT, SeidenD, SainatiSet al. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med, 2006; 7,4:312–318.
7.
MeolieAL, RosenC, KristoD. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med, 2005; 1,2:173–187.
